Adipolin protects against renal injury via PPARα-dependent reduction of inflammasome activation.

Cell biology Immunology Molecular biology

Journal

iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038

Informations de publication

Date de publication:
19 May 2023
Historique:
received: 12 09 2022
revised: 06 02 2023
accepted: 04 04 2023
medline: 30 5 2023
pubmed: 30 5 2023
entrez: 30 5 2023
Statut: epublish

Résumé

Although chronic kidney disease (CKD) is a major health problem worldwide, its underlining mechanism is incompletely understood. We previously identified adipolin as an adipokine which provides benefits for cardiometabolic diseases. Here, we investigated the role of adipolin in the development of CKD. Adipolin-deficiency exacerbated urinary albumin excretion, tubulointerstitial fibrosis and oxidative stress of remnant kidneys in mice after subtotal nephrectomy through inflammasome activation. Adipolin positively regulated the production of ketone body, β-hydroxybutyrate (BHB) and expression of a catalytic enzyme producing BHB, HMGCS2 in the remnant kidney. Treatment of proximal tubular cells with adipolin attenuated inflammasome activation through the PPARα/HMGCS2-dependent pathway. Furthermore, systemic administration of adipolin to wild-type mice with subtotal nephrectomy ameliorated renal injury, and these protective effects of adipolin were diminished in PPARα-deficient mice. Thus, adipolin protects against renal injury by reducing renal inflammasome activation through its ability to induce HMGCS2-dependent ketone body production via PPARα activation.

Identifiants

pubmed: 37250342
doi: 10.1016/j.isci.2023.106591
pii: S2589-0042(23)00668-5
pmc: PMC10214396
doi:

Types de publication

Journal Article

Langues

eng

Pagination

106591

Informations de copyright

© 2023 The Author(s).

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Références

J Am Soc Nephrol. 2006 Jun;17(6):1695-702
pubmed: 16641153
J Biol Chem. 2011 Oct 7;286(40):34552-8
pubmed: 21849507
Cell. 1992 Mar 6;68(5):879-87
pubmed: 1312391
J Am Soc Nephrol. 2015 Mar;26(3):636-46
pubmed: 25071081
Cell Metab. 2020 Sep 1;32(3):404-419.e6
pubmed: 32726607
PLoS One. 2020 Dec 4;15(12):e0243483
pubmed: 33275602
Arterioscler Thromb Vasc Biol. 2002 May 1;22(5):717-26
pubmed: 12006382
BMC Nephrol. 2015 May 30;16:77
pubmed: 26025192
J Am Soc Nephrol. 2010 Oct;21(10):1732-44
pubmed: 20688930
Lancet. 2013 Jul 20;382(9888):260-72
pubmed: 23727169
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Acta Pharmacol Sin. 2015 Jul;36(7):821-30
pubmed: 26005910
Kidney Int. 2005 Nov;68(5):2208-17
pubmed: 16221220
Int Urol Nephrol. 2020 Dec;52(12):2321-2327
pubmed: 32734505
Kidney Int. 2011 Apr;79(8):871-82
pubmed: 21270762
Nature. 2006 Mar 9;440(7081):237-41
pubmed: 16407889
J Biol Chem. 2012 Mar 23;287(13):10301-10315
pubmed: 22275362
J Am Soc Nephrol. 2018 Apr;29(4):1165-1181
pubmed: 29439156
Kidney Int. 2009 Sep;76(5):500-11
pubmed: 19536084
Am J Physiol Heart Circ Physiol. 2013 Apr 15;304(8):H1060-76
pubmed: 23396451
PLoS One. 2013 Dec 16;8(12):e83183
pubmed: 24358263
Arterioscler Thromb Vasc Biol. 2008 May;28(5):863-70
pubmed: 18309113
Lab Invest. 2018 Jun;98(6):773-782
pubmed: 29511302
Nat Med. 2015 Mar;21(3):263-9
pubmed: 25686106
Int J Clin Exp Pathol. 2015 Sep 01;8(9):10653-61
pubmed: 26617775
Am J Pathol. 2014 May;184(5):1287-98
pubmed: 24606883
Cardiovasc Res. 2020 Jan 1;116(1):237-249
pubmed: 30874788
Clin Chim Acta. 2009 May;403(1-2):23-30
pubmed: 19141296
Hemodial Int. 2019 Oct;23(4):472-478
pubmed: 31566300
Heart Fail Rev. 2021 Jul;26(4):947-952
pubmed: 33404998
Arterioscler Thromb Vasc Biol. 2007 Sep;27(9):1910-7
pubmed: 17626903
Prog Cardiovasc Dis. 2018 Jul - Aug;61(2):157-167
pubmed: 29981350
Trends Endocrinol Metab. 2014 Jan;25(1):42-52
pubmed: 24140022
Lancet. 2020 Feb 29;395(10225):709-733
pubmed: 32061315
Nat Rev Nephrol. 2018 Feb;14(2):105-120
pubmed: 29199276
Nat Rev Immunol. 2011 Feb;11(2):85-97
pubmed: 21252989
Am J Physiol Renal Physiol. 2007 Oct;293(4):F1355-62
pubmed: 17686962
Curr Opin Nephrol Hypertens. 2016 May;25(3):208-16
pubmed: 26999023
J Am Soc Nephrol. 2013 Nov;24(11):1727-36
pubmed: 24115475
J Clin Invest. 2008 May;118(5):1645-56
pubmed: 18431508
J Biol Chem. 1994 Jul 22;269(29):18767-72
pubmed: 7913466
J Endocrinol. 2001 Jun;169(3):453-9
pubmed: 11375115
Kidney Int. 2009 Nov;76(10):1049-62
pubmed: 19710628
Biochem Biophys Res Commun. 2012 Nov 9;428(1):155-9
pubmed: 23068097

Auteurs

Lixin Fang (L)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Koji Ohashi (K)

Department of Molecular Medicine and Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Satoko Hayakawa (S)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Hayato Ogawa (H)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Naoya Otaka (N)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Hiroshi Kawanishi (H)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Tomonobu Takikawa (T)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Yuta Ozaki (Y)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Kunihiko Takahara (K)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Minako Tatsumi (M)

Department of Molecular Medicine and Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Mikito Takefuji (M)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Yuuki Shimizu (Y)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Yasuko K Bando (YK)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Yuya Fujishima (Y)

Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.

Norikazu Maeda (N)

Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.

Iichiro Shimomura (I)

Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.

Toyoaki Murohara (T)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Noriyuki Ouchi (N)

Department of Molecular Medicine and Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Classifications MeSH